Cancer Antigen 19-9 (CA 19-9)

CA 19-9 is the main blood marker doctors track in pancreatic and bile-duct cancers. Its strangest quirk: a sizable minority of people are simply built not to produce it at all.

Part of the Tumor Markers — see all 11 values together, including Alpha-Fetoprotein, Beta-hCG, Cancer Antigen 125.

About one person in fifteen cannot make this marker at all, which makes a normal result meaningless for them. CA 19-9 is a protein that certain tumors shed into the blood, and the test measures how much of it is circulating. MedlinePlus describes it as a tumor marker used mainly with pancreatic cancer. But producing CA 19-9 depends on a gene that many people simply do not carry, so the marker behaves less like a universal alarm and more like a language that roughly one person in fifteen is born unable to speak. When they stay quiet, the silence carries no meaning.

The gene in question builds the Lewis antigen, the molecular scaffold CA 19-9 is assembled on. Without it, the body cannot make the marker no matter what is going on inside. Research in Anticancer Research puts the Lewis-negative share at roughly 5 to 10 percent of people of European descent, and higher elsewhere, reaching about 22 percent in one non-Caucasian group. For all of them, the test is reading a phone line that was never connected.

CA 19-9 is reported in units per milliliter (U/mL), with a widely used cutoff of 37 below which results are called normal. For most people that cutoff means something. For the Lewis-negative minority, a number near zero is the only number they will ever produce, cancer or not, so it cannot reassure and cannot warn.

What the numbers usually mean

U/mL
Could be normal, could be a blind spot Near 0 (undetectable)

For the roughly 1 in 15 who are Lewis-negative, the marker reads near zero whatever is happening inside, so this result carries no information either way. For everyone else, a low number does reflect low marker levels.

Within the standard reference range < 37

The common cutoff. Reassuring in people who actually make the marker, yet a normal result on its own neither rules cancer in nor rules it out.

Elevated, needs context Above 37

Benign causes such as gallstones, bile duct infection, and pancreatitis are far more common here than cancer, especially at modest elevations.

Suspicious, still not proof Markedly high

Very high levels favor malignancy, but a severely blocked bile duct can also drive the number up. Doctors read it next to imaging, never alone.

The undetectable band at the top deserves its own sentence. A result that comes back at zero feels like the best possible news, and for most people it is unremarkable. For someone who is Lewis-negative, that same zero is not a clean bill of health. It is the only answer their biology can give.

When a normal CA 19-9 is not reassurance

This is the part that catches people off guard. They search for whether a normal CA 19-9 rules out pancreatic cancer, or wonder why their level came back at zero, and the honest answer is that a low number means different things for different people. MedlinePlus states plainly that some people do not make CA 19-9 even when they have a cancer that usually produces high levels of it, because they lack the Lewis antigen needed to build it.

The size of the blind spot is striking. In a study of Lewis and secretor polymorphisms, 34 of 36 Lewis-negative people had undetectable CA 19-9, about 95 percent, even in the presence of advanced disease. For them, the marker is permanently switched off, so a reassuring result is not evidence of anything.

Even among people who do make CA 19-9, the marker is a poor early-warning system. Work summarized by the NIH found CA 19-9 elevated in only about 40 percent of stage I pancreatic cancers, which means small, early tumors often sit below the cutoff. That combination, a marker that some people cannot produce and that early cancers often do not raise, is why a normal CA 19-9 is never read as proof that nothing is wrong. If you feel unwell and your result looks fine, that result settles less than it seems to.

What does a high CA 19-9 mean?

A number above 37 is the result most people expect to worry about, and it does warrant attention. But modest elevations point toward cancer far less often than toward something benign. MedlinePlus lists several noncancerous conditions that raise CA 19-9, and a blocked or inflamed bile system is the usual culprit.

What can push CA 19-9 high without cancer

  • Gallstones blocking the bile ducts

    Obstruction backs up bile and can lift CA 19-9 substantially, sometimes into the range people associate with malignancy.

  • Cholangitis

    Infection of the bile ducts is a common benign driver of an elevated result.

  • Pancreatitis

    Inflammation of the pancreas itself raises the marker without any tumor present.

  • Cirrhosis and other liver disease

  • Cystic fibrosis

Because benign blockage can mimic cancer on this one number, doctors interpret a high CA 19-9 in context rather than in isolation. It is frequently checked next to CEA, another marker raised in digestive cancers, and read alongside imaging and the clinical picture. A very high level without an obvious blockage raises more concern than a borderline one, but even a striking number is a prompt for further testing, not a diagnosis. As with CA 27-29, a single CA 19-9 value is interpreted with caution, since benign conditions can raise it and the trend across serial measurements is what clinicians actually act on.

The flip side of the screening question explains why. MedlinePlus is explicit that providers do not use CA 19-9 alone to screen or diagnose, and the National Cancer Institute frames its real value as monitoring a cancer that has already been found: tracking pancreatic, gallbladder, bile duct, and gastric cancers and checking whether treatment is working. The marker is most useful watching a known number move, not hunting for disease in people who feel well. Like its relative CA 15-3, CA 19-9 is a monitoring marker whose rate of change matters far more than a single isolated result.

How to read a CA 19-9 result with your doctor

  1. 1

    Ask why it was ordered

    CA 19-9 is built for monitoring a known cancer or its treatment, per the National Cancer Institute, not for screening healthy people. The reason it was drawn shapes how the number should be read.

  2. 2

    Ask whether you make the marker

    If a level is unexpectedly low or undetectable, the Lewis-negative possibility matters. Your doctor can weigh whether a normal result is informative for you at all.

  3. 3

    Recheck after any blockage clears

    A blocked bile duct can raise CA 19-9 on its own, so a value measured during obstruction is hard to trust. Clinicians often repeat it once the blockage and jaundice have settled.

  4. 4

    Read it next to imaging and other markers

    A single CA 19-9 rarely stands alone. Scans, symptoms, and companion markers together carry the interpretation.

CA 19-9 in context

CA 19-9 is one entry in a small family of tumor markers, each tuned to different cancers, that make up the tumor markers panel. Where CA 19-9 leans toward the pancreas and bile system, CA-125 is associated with ovarian cancer, AFP with liver and testicular tumors, and beta-hCG with certain germ cell and trophoblastic cancers. None of them is a standalone test, and each comes with its own caveats about what a high or low value can and cannot mean. For neuroendocrine rather than pancreatic or biliary tumors, clinicians turn to chromogranin A instead, a marker that needs a heartburn-pill check before it can be trusted.

For a marker used mainly to monitor, the direction of travel matters more than any single reading. A CA 19-9 of 60 means one thing if it was 200 before treatment and quite another if it was 20 a month ago, which is why doctors watch the trend over repeated draws. The guide to reading tumor markers walks through interpreting these numbers as a moving picture rather than a verdict, and explains why the same result can be reassuring for one person and uninformative for another.

Try BloodSight

See your Cancer Antigen 19-9 on one timeline.

BloodSight calibrates the reference range to your sex, age, and lab — and shows every value across every visit.

Cancer Antigen 19-9 5 visits
19 U/mL −24
Mar Apr May Jun Jul

In your personal range

Normal ranges

Group Range Unit
Adult Male 0–37 U/mL
Adult Female 0–37 U/mL

Reference ranges may vary by laboratory and individual factors.

Cancer Antigen 19-9 — Common Questions

Can my CA 19-9 be normal even if I have cancer?
Yes. MedlinePlus notes that some people do not make CA 19-9 even when they have a cancer that usually produces high levels, because they lack the Lewis antigen the marker is built on. Beyond that, CA 19-9 is raised in only about 40 percent of stage I pancreatic cancers, so early disease can sit under the cutoff even in people who do produce the marker. A normal result is never used on its own to rule cancer out.
Why is my CA 19-9 zero or undetectable?
For roughly 5 to 10 percent of people, an undetectable result is simply how their body works. They are Lewis-negative, meaning they cannot build the molecular scaffold CA 19-9 sits on, so their level reads near zero regardless of what is happening inside them. In one series, 34 of 36 Lewis-negative people had undetectable CA 19-9 even with advanced disease. For everyone else, a low number genuinely reflects low marker levels.
Can a blocked bile duct or jaundice raise CA 19-9 as high as cancer?
It can. MedlinePlus lists gallstones blocking the bile ducts, bile duct infection, pancreatitis, cirrhosis, and other liver disease among the noncancerous causes of a high CA 19-9. A significant blockage can push the number well into the range people associate with cancer, which is one reason the result is read alongside imaging rather than alone.
Should CA 19-9 be rechecked after jaundice clears?
Often, yes. Because a blocked bile duct can drive the marker up on its own, a level measured during obstruction is hard to interpret. Many doctors repeat the test once the blockage is relieved and the jaundice settles, since the number that remains is easier to trust. Your own care team decides the timing based on your situation.
Is CA 19-9 a good screening test for healthy people?
No. MedlinePlus states that providers do not use CA 19-9 alone to screen or diagnose, and no professional society recommends it as a screening test for average-risk people with no symptoms. The National Cancer Institute describes its main role as monitoring a known cancer and checking whether treatment is working, not finding cancer in healthy people.

Disclaimer

This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.